announced an eight-year strategic partnership with NYU Langone Health to enhance patient care through innovation.
Philips values the deal with NYU Langone, ranked the nation’s top academic medical center by Vizient, at up to $115 million. The company aims to offer new technologies for clinicians to collaborate in real time. This extends to sharing pathology, imaging studies or patient data to support diagnostic confidence and tailor individualized care plans.
According to a news release, they expect the integrated, collaborative approach to further enhance the patient experience. Philips and NYU Langone anticipate faster diagnosis and treatment, plus improved outcomes as a result.
Philips Chief Business Leader for Connected Care, Julia Strandberg, called NYU Langone a “trailblazer” for technology adoption.
“With the adoption of these technologies, they are the forefront of leveraging a new enterprise monitoring platform and business model to help enable a better patient experience, improved staff productivity and reduced cost of care,” Strandberg said. “At the same time, they understand the real value of technology allowing clinicians to focus on what matters most – providing the best care possible to their patients.”
More about the Philips-NYU Langone partnership
Under the agreement, NYU Langone plans to adopt Philips’ IntelliSite Pathology solution and enterprise informatics. It’ll also take on the Dutch medtech giant’s AI-enabled diagnostic imaging technologies like the Philips Lumify handheld ultrasound.
Philips said that, with the support of its innovation and leadership, NYU Langone can apply its industry-leading knowledge of the patient journey and care pathways to help push the boundaries of personalized care.
“As one of the most digitally advanced health systems in the nation, NYU Langone Health empowers our clinicians to easily transform data into insights that can help us further elevate the world-class care and exceptional outcomes we provide to our patients,” said Nader Mherabi, chief digital and information officer at NYU Langone. “Further harnessing big data is the next step in our commitment to ensuring that NYU Langone remains at the forefront of innovation and precision medicine that our patients have to come to expect.”